Related Experiment Video
Updated: Apr 19, 2026

Evaluation of Right Ventricular Function in Experimental Models of Pulmonary Arterial Hypertension
Published on: June 27, 2025
Effect of adenotonsillar hypertrophy on right ventricle function in children
Jin Hwan Lee1, Jung Min Yoon1, Jae Woo Lim1
1Department of Pediatrics, Konyang University College of Medicine, Daejeon, Korea.
Insights
Children with adenotonsillar hypertrophy (ATH) show elevated N-terminal of probrain natriuretic peptide (NT-proBNP) levels, indicating potential cardiac dysfunction. Echocardiography did not reveal significant right ventricle (RV) dysfunction, but NT-proBNP suggests underlying risks.
Area of Science:
- Pediatric Cardiology
- Pulmonology
- Biomarkers
Background:
- Chronic upper airway obstruction, common in children with adenotonsillar hypertrophy (ATH), can lead to hypoxemic pulmonary vasoconstriction and right ventricle (RV) dysfunction.
- ATH is a prevalent cause of upper airway obstruction in pediatric populations.
Purpose of the Study:
- To evaluate right ventricle (RV) function in children diagnosed with adenotonsillar hypertrophy (ATH).
- To investigate the correlation between ATH and potential cardiac dysfunction markers.
Main Methods:
- Inclusion of 21 children with ATH and 21 age- and gender-matched healthy controls.
- Assessment of RV function using tricuspid annular plane systolic excursion and RV myocardial performance index via transthoracic echocardiography.
- Measurement of plasma N-terminal of probrain natriuretic peptide (NT-proBNP) levels as an indicator of RV function.
Main Results:
- Loud snoring was a common symptom reported in the ATH group via the STOP questionnaire.
- Plasma NT-proBNP levels were significantly higher in children with ATH compared to controls (66.44±37.63 pg/mL vs. 27.85±8.89 pg/mL, P=0.001).
- No significant differences in echocardiographic parameters for RV function were observed between the groups.
Conclusions:
- While echocardiographic evidence of RV dysfunction was not confirmed, elevated NT-proBNP suggests a potential risk for cardiac dysfunction in children with chronic airway obstruction due to ATH.
- Further research with larger patient cohorts and transthoracic echocardiography is warranted.
- Pediatricians and otolaryngologists should consider cardiac implications in the management of children with severe ATH.
Purpose:
Chronic upper airway obstruction causes hypoxemic pulmonary vasoconstriction, which may lead to right ventricle (RV) dysfunction. Adenotonsillar hypertrophy (ATH) is the most common cause of upper airway obstruction in children. Therefore, we aimed to evaluate RV function in children with ATH.
Methods:
Twenty-one children (male/female, 15/6; mean age, 92.3¡¾39.0 months; age range, 4-15 years) with ATH and 21 healthy age- and gender-matched controls were included in this study. Tricuspid annular plane systolic excursion and RV myocardial performance index were measured by transthoracic echocardiography. Further, the plasma level of N-terminal of probrain natriuretic peptide (NT-proBNP), an indicator of RV function, was determined.
Results:
The snoring-tiredness during daytime-observed apnea-high blood pressure (STOP) questionnaire was completed by the patients' parents, and loud snoring was noted in the ATH group. The plasma NT-proBNP level was significantly higher in the ATH group than that in the controls (66.44±37.63 pg/mL vs. 27.85±8.89 pg/mL, P=0.001). The echocardiographic parameters were not significantly different between the groups.
Conclusion:
We were unable to confirm the significance of echocardiographic evidence of RV dysfunction in the management of children with ATH. However, the plasma NT-proBNP level was significantly higher in the ATH group than that in the control, suggesting that chronic airway obstruction in children may carry a risk for cardiac dysfunction. Therefore, more patients should be examined using transthoracic echocardiography. In addition, pediatricians and otolaryngologists should consider cardiologic aspects during the management of children with severe ATH.
More Related Videos
09:40Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice
Published on: May 13, 2019
06:04Author Spotlight: Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model
Published on: June 9, 2023
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Cellular Adaptation II: Hypertrophy